ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,464,585 | -17.8% | 123,913 | -9.9% | 3.31% | -22.0% |
| Q4 2022 | $5,432,498 | -3.4% | 137,462 | -1.7% | 4.24% | +17.4% |
| Q3 2022 | $5,621,000 | -19.5% | 139,890 | -15.7% | 3.61% | -2.9% |
| Q2 2022 | $6,980,000 | +75.6% | 166,040 | +62.7% | 3.72% | +120.0% |
| Q1 2022 | $3,976,000 | -24.8% | 102,052 | -23.0% | 1.69% | +24.5% |
| Q4 2021 | $5,285,000 | -6.2% | 132,613 | -14.9% | 1.36% | +19.6% |
| Q3 2021 | $5,632,000 | -63.8% | 155,848 | -59.0% | 1.14% | -53.9% |
| Q2 2021 | $15,579,000 | -21.2% | 380,061 | -16.1% | 2.46% | -15.8% |
| Q1 2021 | $19,758,000 | +100.6% | 452,948 | +130.2% | 2.93% | +117.6% |
| Q4 2020 | $9,849,000 | – | 196,790 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |